Your browser doesn't support javascript.
loading
Preoperative serum chromogranin-a is predictive of survival in locoregional jejuno-ileal small bowel neuroendocrine tumors.
Chatani, Praveen D; Aversa, John G; McDonald, James D; Khan, Tahsin M; Keutgen, Xavier M; Nilubol, Naris.
Affiliation
  • Chatani PD; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Aversa JG; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • McDonald JD; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Khan TM; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Keutgen XM; Department of Surgery, Division of General Surgery and Surgical Oncology, Endocrine Surgery Research Program, University of Chicago Medicine, Chicago, IL.
  • Nilubol N; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: niluboln@mail.nih.gov.
Surgery ; 170(1): 106-113, 2021 07.
Article in En | MEDLINE | ID: mdl-33814188
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Neuroendocrine Tumors / Chromogranin A / Ileal Neoplasms / Jejunal Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Neuroendocrine Tumors / Chromogranin A / Ileal Neoplasms / Jejunal Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article